Review of current treatment in panic disorder

被引:24
|
作者
den Boer, JA [1 ]
Slaap, BR [1 ]
机构
[1] Acad Hosp Groningen, Psychiat Univ Clin, NL-9700 RB Groningen, Netherlands
关键词
anxiety; benzodiazepines; panic attacks; panic disorder; selective serotonin reuptake inhibitors; tricyclic antidepressants;
D O I
10.1097/00004850-199804004-00005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ideal properties for an antipanic agent include the ability to provide complete recovery from panic attacks, resolution of associated anxiety and avoidance behavior, relapse prevention, good tolerability, and efficacy in comorbid conditions including depression. We compared the properties of currently available treatment options for panic attacks, including the benzodiazepines, tricyclic antidepressants, monoamine oxidase inhibitors and selective serotonin reuptake inhibitors (SSRIs), with this ideal. Experimental approaches in the development of therapeutic agents of potential use against panic disorder were also examined. It is clear that SSRIs, such as paroxetine, are an effective treatment for panic disorder, and their antidepressant activity also allows concurrent treatment of comorbid depressive disorders, for which patients with panic disorder are at high risk. However, despite the availability of effective antipanic agents, some patients do not respond to treatment. (C) 1998 Lippincott-Raven Publishers.
引用
收藏
页码:S25 / S30
页数:6
相关论文
共 50 条
  • [1] Smoking and panic attacks, panic disorder, and agoraphobia: A review of the empirical literature
    Zvolensky, MJ
    Feldner, MT
    Leen-Feldner, EW
    McLeish, AC
    CLINICAL PSYCHOLOGY REVIEW, 2005, 25 (06) : 761 - 789
  • [2] Panic disorder: Clinical features and treatment approaches
    Chutko, L. S.
    Surushkina, S. Yu.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (08) : 133 - 137
  • [3] Current Pharmacological Interventions in Panic Disorder
    Freire, Rafael C.
    Machado, Sergio
    Arias-Carrion, Oscar
    Nardi, Antonio E.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (06) : 1057 - 1065
  • [4] Clonazepam for the Treatment of Panic Disorder
    Nardi, Antonio E.
    Machado, Sergio
    Almada, Leonardo Ferreira
    Paes, Flavia
    Silva, Adriana Cardoso
    Marques, Ricardo Jose
    Amrein, Roman
    Freire, Rafael C.
    Martin-Santos, Rocio
    Cosci, Fiammeta
    Hallak, Jaime E.
    Crippa, Jose A.
    Arias-Carrion, Oscar
    CURRENT DRUG TARGETS, 2013, 14 (03) : 353 - 364
  • [5] Ondansetron in the treatment of panic disorder
    Schneier, FR
    Garfinkel, R
    Kennedy, B
    Campeas, R
    Fallon, B
    Marshall, R
    ODonnell, L
    Hogan, T
    Liebowitz, MR
    ANXIETY, 1996, 2 (04): : 199 - 202
  • [6] Treatment Strategies of Obsessive-Compulsive Disorder and Panic Disorder/Agoraphobia
    Marazziti, Donatella
    Carlini, Marina
    Dell'Osso, Liliana
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (04) : 238 - 253
  • [7] Can regular physical exercise be a treatment for panic disorder? A systematic review
    Machado, Sergio
    Telles, George
    Magalhaes, Franklin
    Teixeira, Diogo
    Amatriain-Fernandez, Sandra
    Budde, Henning
    Imperatori, Claudio
    Murillo-Rodriguez, Eric
    Monteiro, Diogo
    Correia, Diogo Telles
    Sa Filho, Alberto Souza
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2022, 22 (01) : 53 - 64
  • [8] Panic disorder: A review of clinical research
    Waikar, SV
    Craske, MG
    IN SESSION-PSYCHOTHERAPY IN PRACTICE, 1995, 1 (03) : 21 - 33
  • [9] Treatment-resistant panic disorder: a systematic review
    Freire, Rafael C.
    Zugliani, Morena M.
    Garcia, Rafael F.
    Nardi, Antonio E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (02) : 159 - 168
  • [10] Panic disorder: from psychopathology to treatment
    Perna, G.
    JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2012, 18 (01): : 82 - 91